Trial Profile
Phase II, Multi-Center, Randomized, Double-Blind Study of Nitazoxanide Tablets Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2009
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Peginterferon alfa-2b
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 03 Jun 2009 New trial record.